Related Experiment Video
Updated: Aug 8, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Cytokine profile in acute myelofibrosis associated with aggressive large granular lymphocyte leukemia
B I Dalal1, P A Keown, F Paraskevas
1Division of Hematopathology, Vancouver General Hospital, BC, Canada.
Insights
This study details a rare case of acute large granular lymphocyte (LGL) leukemia mimicking acute myelofibrosis (AMF). The T-cell leukemia exhibited specific genetic and cytokine profiles, including high Transforming Growth Factor-beta 1.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Large granular lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder.
- Acute myelofibrosis (AMF) is a distinct clinicopathologic entity characterized by bone marrow fibrosis.
- The co-occurrence of LGL leukemia presenting as AMF is exceptionally uncommon.
Observation:
- A patient presented with clinical and hematological features suggestive of acute myelofibrosis.
- Flow cytometry revealed immature T-cells with a specific immunophenotype (CD5+, CD7+, CD16-, CD56-, CD57-, CD41-).
- Genetic analysis identified monosomy 7 in the leukemic cells.
Findings:
- The leukemic cells were found to secrete substantial amounts of Transforming Growth Factor-beta 1 (TGF-beta 1).
- Elevated serum levels of Interleukin-2 (IL-2), IL-2 receptor (IL-2R), IL-6, and IL-8 were observed.
- Serum levels of IL-1 beta, IL-4, and tumor necrosis factor-alpha remained within normal ranges.
Implications:
- This case expands the understanding of LGL leukemia's diverse clinical presentations.
- The findings highlight the potential role of TGF-beta 1 and specific interleukins in the pathogenesis of this LGL leukemia subtype.
- Further research may elucidate the mechanisms linking T-cell leukemia, myelofibrosis, and cytokine dysregulation.
Abstract:
We report a patient with acute large granular lymphocyte (LGL) leukemia, presenting as acute myelofibrosis (AMF). The leukemic cells were immature T-cells (CD5+, CD7+, CD16-, CD56-, CD57-, and CD41-), had monosomy 7, and secreted large amounts of Transforming Growth Factor-beta 1(TGF-beta 1). The serum levels of interleukins (IL)-2, -2R, -6 and -8 were elevated, while the IL-1 beta, IL-4, and tumor necrosis factor-alpha were normal.

